Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial.

Purpose: Medical podcast integration into hematology/oncology fellowship curricula remains largely unstudied. We conducted a multicenter cluster randomized trial to evaluate the educational impact of a podcast-based curriculum (PC) when delivered alongside standard didactics compared with standard didactics alone.

Methods: Twenty-seven US Accreditation Council for Graduate Medical Education-accredited hematology/oncology fellowship programs were randomized to receive either PC plus standard didactics (podcast arm, n = 14) or standard didactics alone (control arm, n = 13).

Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphoma.

Indolent CNS lymphomas (CNSLs) are rare and no guidelines exist for management. Recent literature highlights the potential for safe and tolerable intrathecal (IT) delivery of rituximab, a large anti-CD20 monoclonal antibody, for aggressive CNSL. We report a patient with relapsed indolent CNSL who failed systemic rituximab and could not tolerate IT chemotherapies, but had an objective response of 6 months duration to IT rituximab.